Literature DB >> 34232476

Precocious White Matter Inflammation and Behavioural Inflexibility Precede Learning and Memory Impairment in the TgAPP21 Rat Model of Alzheimer Disease.

Alexander Levit1, Andrew Gibson1, Olivia Hough1, Youngkyung Jung1, Yuksel Agca2, Cansu Agca2, Vladimir Hachinski3, Brian L Allman1, Shawn N Whitehead4,5.   

Abstract

Neuroinflammation and behavioural inflexibility are both common in late adulthood but far more profound in Alzheimer disease (AD). To investigate the relationship between ageing, AD, neuroinflammation, and behavioural flexibility, male wild-type Fischer 344 (Wt) and the transgenic APP21 (TgAPP21) rats were aged to 4, 8, 13, and 22 months and evaluated for neuroinflammation and cognitive impairment. TgAPP21 rats overexpress a pathogenic variant of the human amyloid precursor protein (hAPP; Swedish and Indiana mutations) but do not spontaneously develop overt pathology related to AD. In both genotypes, learning and memory were similarly impaired in older rats. However, at 8 months of age, TgAPP21 rats demonstrated behavioural inflexibility in set shifting, reversal, and the Morris water maze, while Wt rats showed inflexibility at 13 and 22 months of age. This early inflexibility in TgAPP21 rats was accompanied by a precocious increase in microglia activation within the corpus callosum; 8- and 13-month-old TgAPP21 rats had similar levels of microglia activation as 13- and 22-month-old Wt rats, respectively. However, while neuroinflammation within the white matter continued to progress with age, behavioural inflexibility peaked in 8-month-old TgAPP21 rats; in older TgAPP21 rats, memory and learning impairments masked inflexibility. These findings suggest that the behavioural inflexibility and white matter inflammation seen in normal ageing are accelerated in AD and may precede impairments of learning and memory.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Ageing; Alzheimer disease; Behavioral flexibility; Executive function; Microglia; White matter

Mesh:

Year:  2021        PMID: 34232476     DOI: 10.1007/s12035-021-02476-w

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  40 in total

Review 1.  Insights into the ageing mind: a view from cognitive neuroscience.

Authors:  Trey Hedden; John D E Gabrieli
Journal:  Nat Rev Neurosci       Date:  2004-02       Impact factor: 34.870

2.  Cognitive aging, executive function, and fractional anisotropy: a diffusion tensor MR imaging study.

Authors:  S M Grieve; L M Williams; R H Paul; C R Clark; E Gordon
Journal:  AJNR Am J Neuroradiol       Date:  2007-02       Impact factor: 3.825

3.  White matter changes with normal aging.

Authors:  C R Guttmann; F A Jolesz; R Kikinis; R J Killiany; M B Moss; T Sandor; M S Albert
Journal:  Neurology       Date:  1998-04       Impact factor: 9.910

Review 4.  Executive functions.

Authors:  Adele Diamond
Journal:  Annu Rev Psychol       Date:  2012-09-27       Impact factor: 24.137

5.  The cognitive correlates of white matter abnormalities in normal aging: a quantitative review.

Authors:  F M Gunning-Dixon; N Raz
Journal:  Neuropsychology       Date:  2000-04       Impact factor: 3.295

6.  Peroxisome proliferator-activated receptor-γ agonist pioglitazone ameliorates white matter lesion and cognitive impairment in hypertensive rats.

Authors:  Lin-Fang Lan; Lu Zheng; Xian Yang; Xiao-Tan Ji; Yu-Hua Fan; Jin-Sheng Zeng
Journal:  CNS Neurosci Ther       Date:  2015-01-22       Impact factor: 5.243

Review 7.  Normal cognitive aging.

Authors:  Caroline N Harada; Marissa C Natelson Love; Kristen L Triebel
Journal:  Clin Geriatr Med       Date:  2013-11       Impact factor: 3.076

8.  Dimethyl fumarate improves white matter function following severe hypoperfusion: Involvement of microglia/macrophages and inflammatory mediators.

Authors:  Jill H Fowler; Jamie McQueen; Philip R Holland; Yasmina Manso; Martina Marangoni; Fiona Scott; Emma Chisholm; Robert H Scannevin; Giles E Hardingham; Karen Horsburgh
Journal:  J Cereb Blood Flow Metab       Date:  2017-06-13       Impact factor: 6.200

9.  Minocycline reduces microgliosis and improves subcortical white matter function in a model of cerebral vascular disease.

Authors:  Yasmina Manso; Philip R Holland; Akihiro Kitamura; Stefan Szymkowiak; Jessica Duncombe; Edel Hennessy; James L Searcy; Martina Marangoni; Andrew D Randall; Jon T Brown; Barry W McColl; Karen Horsburgh
Journal:  Glia       Date:  2017-07-19       Impact factor: 7.452

Review 10.  White matter degeneration in vascular and other ageing-related dementias.

Authors:  Yoshiki Hase; Karen Horsburgh; Masafumi Ihara; Raj N Kalaria
Journal:  J Neurochem       Date:  2018-01-09       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.